Early Electronic Specialist-led Diabetes Care Improves Postdischarge Glycemia: The STOIC-D Surgery Follow-up Cohort
The Journal of Clinical Endocrinology & Metabolism · 21.01.2026 · 111 (2) · e375-e381
DOI: 10.1210/clinem/dgaf440 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 01.08.2025. Verfasst von Isuru L Gamage und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes & Endocrinology, The Royal Melbourne Hospital, Melbourne, Victoria 3050, Australia. Hauptthemen laut MEDLINE: Glycemic Control, Hyperglycemia, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Rowe Family Foundation Perpetual Grant, The Royal Melbourne Hospital Home Lottery Victor Hurley, Australian Government Research Training Program Scholarship.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Objective
To assess the effect of an early, electronic specialist-led model of inpatient diabetes care on glycemic outcomes following discharge and rates of treatment intensification.
Methods
The STOIC-D trial has demonstrated early, electronic specialist-led care by an inpatient diabetes service reduces inpatient hyperglycemia. This follow-up study assessed glycemic outcomes following discharge in a subgroup of 360 STOIC-D trial patients with admission glycated hemoglobin (HbA1c) ≥ 7% and alive 1 year following hospitalization. First available HbA1c between 3 and 15 months following discharge was collected. Multivariable logistic regression identified predictors of clinically significant reduction in HbA1c, defined as ≥0.5%. Multivariable linear regression assessed correlation of baseline characteristics with change in HbA1c. Multivariable logistic regression identified predictors of treatment intensification in hospital.
Results
The early intervention arm experienced a greater HbA1c reduction following hospitalization (0.4% [3.9 mmol/mol] vs -0.04% [-0.4 mmol/mol]) compared with preadmission (P = .02). Clinically significant reduction in HbA1c occurred more frequently in the intervention arm (45% vs 31% [P = .01], adjusted odds ratio [aOR] 1.8; 95% CI, 1.1-2.9). Adjusted multivariable linear regression demonstrated inclusion in the intervention arm correlated with proportional reduction in posthospitalization HbA1c. Treatment intensification was more common in the intervention compared with control (36% vs 19% [P = .002], aOR 2.2 [95% CI: 1.3-3.6]). In a subanalysis of participants with admission HbA1c of 7% to 8.5%, age <75 years, the aOR for treatment intensification with early intervention was 4.0 (95% CI, 1.6-11.1).
Conclusion
Treatment intensification and posthospitalization HbA1c improved following intervention with an early, electronic specialist-led consultation in hospital.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Diabetes & Endocrinology, The Royal Melbourne Hospital, Melbourne, Victoria 3050, Australia.
- Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, Melbourne, Victoria 3050, Australia.
- Australian Centre for Accelerating Diabetes Innovations (ACADI), The University of Melbourne, The Royal Melbourne Hospital, Melbourne, Victoria 3050, Australia.
- National Centre for Infections in Cancer (NCIC), Sir Peter MacCallum Department of Oncology, The University of Melbourne, The Royal Melbourne Hospital, Melbourne, Victoria 3050, Australia.
- Victorian Healthcare Associated Infection Surveillance System (VICNISS) Coordinating Centre, Doherty Institute, The Royal Melbourne Hospital, Melbourne, Victoria 3050, Australia.
ORCID-Profile: Isuru L Gamage, Rahul D Barmanray, Mervyn Kyi, Peter G Colman, Minh V Le, Leon J Worth
Förderung
- Rowe Family Foundation Perpetual Grant
- The Royal Melbourne Hospital Home Lottery Victor Hurley
- Australian Government Research Training Program Scholarship
Zitieren
APA
Gamage, I. L., Barmanray, R. D., Kyi, M., Colman, P. G., Sun, E., Le, M. V., Worth, L. J., & Fourlanos, S. (2026). Early Electronic Specialist-led Diabetes Care Improves Postdischarge Glycemia: The STOIC-D Surgery Follow-up Cohort. The Journal of Clinical Endocrinology & Metabolism, 111(2), e375-e381. https://doi.org/10.1210/clinem/dgaf440
Vancouver
Gamage IL, Barmanray RD, Kyi M, Colman PG, Sun E, Le MV, et al. Early Electronic Specialist-led Diabetes Care Improves Postdischarge Glycemia: The STOIC-D Surgery Follow-up Cohort. The Journal of Clinical Endocrinology & Metabolism. 2026;111(2):e375-e381. doi:10.1210/clinem/dgaf440
BibTeX
@article{Gamage2026,
author = {Gamage, Isuru L and Barmanray, Rahul D and Kyi, Mervyn and Colman, Peter G and Sun, Emily and Le, Minh V and Worth, Leon J and Fourlanos, Spiros},
title = {Early Electronic Specialist-led Diabetes Care Improves Postdischarge Glycemia: The STOIC-D Surgery Follow-up Cohort},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2026},
volume = {111},
number = {2},
pages = {e375--e381},
doi = {10.1210/clinem/dgaf440}
}
EUVIMED